Fig. 3From: Insights of different analytical approaches for estimation of budesonide as COVID-19 replication inhibitor in its novel combinations: green assessment with AGREE and GAPI approachesAbsorption spectra of a BUD (6 μg mL−1) and b AZL (25.0 μg mL−1) in acetonitrileBack to article page